Activity of TNT: a phase 2 study using talimogene laherparepvec, nivolumab and trabectedin for previously treated patients with advanced sarcomas (NCT# 03886311)

por Chawla, Sant P., Tellez, Walter Andree, Chomoyan, Hripsime, Valencia, Chrysler, Ahari, Amir, Omelchenko, Nadezhda, Makrievski, Stefan, Brigham, Don A., Chua-Alcala, Victoria, Quon, Doris, Moradkhani, Ania, Gordon, Erlinda M.
Publicado 2023